FMP
NASDAQ
27.13 USD
-0.19 (-0.7%)
Mr. William H. Lewis J.D., M.B.A.
Healthcare
Biotechnology
https://www.insmed.com
NASDAQ
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated ...
0001104506
US4576693075
457669307
700 US Highway 202/206
908 977 9900
US
912
Jun 1, 2000
0001104506
NASDAQ
Biotechnology
Healthcare
457669307
US4576693075
US
27.13
0.92
1.64M
4.03B
-
16.26-32.0
25.32
-
-
-
-
-5.08
-
https://www.insmed.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.